Recent advances in the genetics of phaeochromocytoma and functional paraganglioma

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 4, 2008, Pages 376-379

  Gimenez Roqueplo, Anne Paule ^a,b,c   Burnichon, Nelly ^a,b,c   Amar, Laurence ^a,b,c   Favier, Judith ^c   Jeunemaitre, Xavier ^a,b,c   Plouin, Pierre François ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

Genetics; Paraganglioma; Phaeochromocytoma

Indexed keywords

SUCCINATE DEHYDROGENASE;

ANGIOGENESIS; CONFERENCE PAPER; ENZYME INACTIVATION; FAMILIAL DISEASE; FRANCE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; GERM LINE; HIGH RISK PATIENT; HUMAN; HUMAN GENETICS; HYPOXIA; METASTASIS; NF1 GENE; PARAGANGLIOMA; PHENOTYPE; PHEOCHROMOCYTOMA; PROGNOSIS; RET GENE; SDHB GENE; SDHD GENE; TUMOR SUPPRESSOR GENE; VHL GENE;

GENETIC COUNSELING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRON-SULFUR PROTEINS; MITOCHONDRIA; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS C-RET; SUCCINATE DEHYDROGENASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 40149104979     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04881.x     Document Type: Conference Paper

References (23)

1. Dluhy RG. Pheochromocytoma - death of an axiom. N. Engl. J. Med. 2002 346 : 1486 8.
2. Baysal BE, Ferrell RE, Willet-Brozick JE et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000 287 : 848 51.
3. Astuti D, Latif D, Latif L et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 2001 69 : 49 54.
4. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 2000 26 : 268 70.
5. DeLellis RA, Lloyd RV, Heitz PU et al. Pathology and genetics of tumours of endocrine organs. In : Kleihues P, Sobin LE (eds). World Health Organization Classification of Tumours. IARC Press, Lyon. 2004 138 59.
6. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005 366 : 665 75.
7. Neumann HP, Bausch B, Mc Whinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 2002 346 : 1459 66.
8. Gimenez-Roqueplo AP, Favier J, Rustin P et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res. 2003 63 : 5615 21.
9. Amar L, Bertherat J, Baudin E et al. Genetic testing in pheochromocytoma and functional paraganglioma. J. Clin. Oncol. 2005 23 : 8812 18.
10. Plouin PF, Gimenez-Roqueplo AP. Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas. Best Pract. Res. Clin. Endocrinol. Metab. 2006 20 : 421 34.
11. Timmers H, Kozupa A, Einsenhofer G et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J. Clin. Endocrinol. Metab. 2007 92 : 779 86.
12. Amar L, Baudin E, Burnichon N et al. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. J. Clin. Endocrinol. Metab. 2007 92 : 3822 8.
13. Chen F, Kishida T, Yao M et al. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 1995 5 : 66 75.
14. Benn DE, Gimenez-Roqueplo AP, Reilly JR et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J. Clin. Endocrinol. Metab. 2006 91 : 827 36.
15. Gimenez-Roqueplo AP, Lehnert H, Mannelli H et al. Phaeochromocytoma, new genes and screening strategies. Clin. Endocrinol. (Oxf) 2006 65 : 699 705.
16. Plouin PF, Gimenez-Roqueplo AP. The genetic basis of pheochromocytoma: Who to screen and how? Nat. Clin. Pract. Endocrinol. Metab 2006 2 : 60 1.
17. Pacak K, Ahlman H, Eisenhofer G et al. Pheochromocytoma: Recommendations for clinical practice from the First International Symposium October 2005. Nat. Clin. Pract. Endocrinol. Metab. 2007 3 : 92 102.
18. Benn DE, Richardson AL, Marsh DJ, Robinson B. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Ann. NY Acad. Sci. 2006 1073 : 104 11.
19. Gimenez-Roqueplo AP, Favier J, Rustin P et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 2001 69 : 1186 97.
20. Gimenez-Roqueplo AP, Favier J, Rustin P et al. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J. Clin. Endocrinol. Metab. 2002 87 : 4771 4.
21. Brière JJ, Favier J, Gimenez-Roqueplo AP, Rustin P. Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation. Am. J. Physiol. Cell Physiol. 2006 291 : C1114 20.
22. Brière JJ, Favier J, Benit P et al. Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum. Mol. Genet. 2005 14 : 3263 9.
23. King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer. Oncogene 2006 25 : 4675 82.